ZFAS1 and neoplasm: Based on the relative ZFAS1 expression in tumor tissues, the 30 CRC patients were classified into two groups: the high-ZFAS1 group (n = 20, fold change ≥2) and the low-ZFAS1 group (n = 10, fold change < 2).